Results 191 to 200 of about 81,923 (241)

Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites. [PDF]

Vaccines (Basel)
Hammitt LL, Buchwald UK, McCauley J, Shekar T, Fu W, Cheon K, Sterling T, Tamms G, Banniettis N, Musey L, LeBlanc JJ, Weatherholtz R, Riley DP, Denny E, Tso C, Roessler K, Santosham M.   +16 more
europepmc   +1 more source

Flexible Loading Phase Treat-and-Extend Regimen with Faricimab for Neovascular Age-Related Macular Degeneration: A Real-World Study. [PDF]

Biomedicines
Machida A, Kurihara J, Hirata Y, Machida E, Murakami R, Oka A, Yoneda A, Tsuiki E, Oishi A.   +8 more
europepmc   +1 more source

Trends in Women's Empowerment and Their Association with Childhood Vaccination in Cambodia: Evidence from Demographic and Health Surveys (2010-2022). [PDF]

Vaccines (Basel)
Song H, Zhang Y, Long Q.
europepmc   +1 more source

The Crucial Role of Noncovalent Interactions in PLGA Nanoparticles: Impact on Carvacrol/<i>p</i>‑Cymene Release, Biological Activity, and Antibiofilm Properties. [PDF]

ACS Omega
Romero-Montero A, Medel E, Gutiérrez-Flores J, García-Aguirre I, Vargas R, Del Prado-Audelo ML.   +5 more
europepmc   +1 more source

Optic nerve sheath diameter and Pcv-aCO₂/Ca-cvO₂ for predicting outcomes in traumatic brain injury patients during prehospital care: a prospective cohort study in China. [PDF]

BMJ Open
Jiang H, Wang H, Xie Z, Yang L.
europepmc   +1 more source

Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines. [PDF]

Cancers (Basel)
Chen M, Kane T, Chen I, Supabphol S, Zhang X, Wolfarth AA, Choi D, Li L, Goedegebuure SP, Gillanders WE.   +9 more
europepmc   +1 more source